ESC 365 - Response to heart failure treatment in patients with anthracyclines and trastuzumab induced left ventricular dysfunction.

ESC Professional Premium Access

Response to heart failure treatment in patients with anthracyclines and trastuzumab induced left ventricular dysfunction.

Session: Chronic heart failure - Cardiotoxicity of drugs

Topic: Cardiotoxicity of Drugs and Other Therapies

Speaker: Doctor S. del Castillo (Buenos Aires, AR)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Santiago del Castillo

Italian Hospital of Buenos Aires, Buenos Aires (Argentina)

0 follower

3 more presentations in this session

Long-term cardiac adverse effects after modern Hodgkins lymphoma treatment

Speaker: Doctor A. Bjerring (Oslo, NO)

Cardiac pressure overload exposes hidden anthracycline-induced cardiotoxicity: Results from a preclinical large-animal trial

Speaker: Mr C. Galan (Madrid, ES)

Usefulness of ultra-sensitive troponin to predict anthracyclines and trastuzumab related cardiac dysfunction

Speaker: Doctor S. del Castillo (Buenos Aires, AR)

Access the full session

Chronic heart failure - Cardiotoxicity of drugs

Speakers: Doctor S. del Castillo, Doctor A. Bjerring, Mr C. Galan, Doctor S. del Castillo

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources